Oluwatobi Arisa

Also affiliated with National Institutes of Health Clinical Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma”.

Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma

New England Journal of Medicine(2024)10.1056/nejmoa2401532

N/A

1.5DataRank · unranked

68 citations

Rahul Lakhotia, Stefania Pittaluga, James D. Phelan, Da Wei Huang, George W. Wright +31 more

Navigating the oncology drug discovery and development process with programmes supported by the National Institutes of Health

The Lancet Oncology(2024)10.1016/s1470-2045(24)00348-6

N/A

0.292DataRank · unranked

6 citations

Erica L. Beatson, Annieka Reno, Cindy H. Chau, Rosemarie Aurigemma, Patricia S. Steeg +2 more

Pharmacokinetic and pharmacodynamic results from a randomized controlled study with the growth hormone secretagogue receptor blocker PF-5190457 in recently abstinent patients with alcohol use disorder

The International Journal of Neuropsychopharmacology(2025)10.1093/ijnp/pyaf081

N/A

0.104DataRank · unranked

1 citations

Rabea K Pfaff, R M Naseer Khan, Anna Loftén, Ryan Zurick, Yi Arial Zeng +6 more

Colesevelam for Lenalidomide Associated Diarrhea in Patients with Multiple Myeloma

Research Square(2024)10.21203/rs.3.rs-4406606/v1

N/A

0.104DataRank · unranked

1 citations

Hani Hassoun, Neha Korde, Kylee Maclachlan, Sham Mailankody, Dhwani Patel +26 more

In Silico Re‐Optimization of Atezolizumab Dosing Using Population Pharmacokinetic Simulation and Exposure–Response Simulation

The Journal of Clinical Pharmacology(2023)10.1002/jcph.2203

N/A

0DataRank · unranked

14 citations

Keith T. Schmidt, Oluwatobi Arisa, William J. Richardson, Koosha Paydary, Daniel A. Goldstein +4 more

Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-0855

N/A

0DataRank · unranked

23 citations

Wei Zhang, Seth M. Steinberg, Darryl Nousome, Nicole Houston, Xiaolin Wu +22 more

PARP inhibitors: A review of the pharmacology, pharmacokinetics, and pharmacogenetics

Seminars in Oncology(2023)10.1053/j.seminoncol.2023.09.005

N/A

0DataRank · unranked

83 citations

Oluwatobi Arisa, Cody J. Peer, Antonio Tito Fojo, William D. Figg, Yi Zeng

Recent Advances in Bioanalytical Methods for Quantification and Pharmacokinetic Analyses of Antibody–Drug Conjugates

The AAPS Journal(2025)10.1208/s12248-025-01115-9

N/A

0DataRank · unranked

16 citations

Yi Zeng, Abdul-Azeez Lanihun, Oluwatobi Arisa, Jonathan Horner, William D. Figg +1 more

Sustained Interferon Signature Suppression With Anifrolumab in a Patient With STING‐Associated Vasculopathy with Onset in Infancy Refractory to JAK Inhibitor and Dazukibart Therapy

Arthritis & Rheumatology(2025)10.1002/art.43145

N/A

0DataRank · unranked

14 citations

Bjoern Buehring, Adriana A. de Jesus, Sachin Gaurav, Andre Rastegar, Alexi Baumgardner +9 more

Determination of metarrestin (ML-246) in human plasma for a first-in-human clinical pharmacokinetic application by a simple and efficient uHPLC-MS/MS assay

Journal of Chromatography B(2023)10.1016/j.jchromb.2023.123738

N/A

0DataRank · unranked

2 citations

Sara Zimmerman, Annieka Reno, Natalia Corvalan Cabanas, Oluwatobi Arisa, Rushikesh Sable +3 more